Application | Comment | Organism |
---|---|---|
drug development | the enzyme is an attractive antiviral drug target because it is essential for coronaviral replication. Targeting the enzyme with antiviral drugs may have an advantage in not only inhibiting viral replication but also inhibiting the dysregulation of signaling cascades in infected cells that may lead to cell death in surrounding, uninfected cells | Severe acute respiratory syndrome-related coronavirus |
Crystallization (Comment) | Organism |
---|---|
apoenzyme and enzyme in complexes with ubiquitin, and inhibitors 5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, N-(1,3-benzodioxol-5-ylmethyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide, N-(4-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide, and N-(3-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide, sitting drop vapor diffusion method, apoenzyme by mixing of 1.1-20 mg/ml protein in 20 mM Tris, pH 7.5, 10 mM DTT, with 100 mM sodium citrate, pH 5.2, 3 M ammonium sulfate. Enzyme-inhibitor N-(1,3-benzodioxol-5-ylmethyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide complex by mixing of 5 mg/ml protein in 20 mM Tris, pH 7.5, 10 mM DTT, with 1 mM inhibitor, 1 M (NH4)2SO4, 50 mM MES, pH 6.5, and 2.5% PEG 400. Enzyme-inhibitor 5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide by mixing of 8 mg/ml protein in 20 mM Tris, pH 7.5, 10 mM DTT with 0.20 mM inhibitor, 1 M LiCl2, 0.1 M MES pH 6.0, 30% PEG 6000. Enzyme-inhibitor N-(3-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide or N-(4-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide complex by mixing of 6 and 12 mg/ml protein, respectively, in 25 mM Tris, pH 7.5, 100 mM NaCl, 10 mM DTT with 0.20 mM inhibitor, 100 mM sodium citrate, pH 5.5, 40% v/v PEG 600. Enzyme-ubiquitin complex by mixing of 3-12 mg/ml protein and ubiquitin in 20 mM Tris, pH 7.5, with 0.1 M CHES, pH 9.5, 18% PEG 3000, X-ray diffraction structure determination and analysis at 1.4-2.75 A resolution | Severe acute respiratory syndrome-related coronavirus |
Protein Variants | Comment | Organism |
---|---|---|
C112S | site-directed mutagenesis, active site cysteine mutant, forms a noncovalent complex with ubiquitin, crystal structure analysis | Severe acute respiratory syndrome-related coronavirus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(4E)-1,7-bis(3,4-dihydroxyphenyl)hept-4-en-3-one | a natural diarylheptanoide inhibitor | Severe acute respiratory syndrome-related coronavirus | |
(7R)-5,7-dihydroxy-8-(4-hydroxy-3-methoxyphenyl)-2-(4-hydroxy-4-methylpentyl)-2-methyl-3,4,7,8-tetrahydro-2H,6H-pyrano[3,2-g]chromen-6-one | a natural geranylated flavonoid inhibitor | Severe acute respiratory syndrome-related coronavirus | |
1,6,6-trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione | a natural tanshinone inhibitor | Severe acute respiratory syndrome-related coronavirus | |
2-methyl-N-[(1R)-1-(naphthalen-2-yl)ethyl]benzamide | over 90% inhibition at 0.1 mM | Severe acute respiratory syndrome-related coronavirus | |
2-methyl-N-[(1S)-1-(naphthalen-2-yl)ethyl]benzamide | 14% inhibition at 0.1 mM | Severe acute respiratory syndrome-related coronavirus | |
2-methyl-N-[1-(naphthalen-2-yl)ethyl]benzamide | racemat | Severe acute respiratory syndrome-related coronavirus | |
5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide | R-isomer, a potent, noncovalent, competitive inhibitor | Severe acute respiratory syndrome-related coronavirus | |
6-Mercaptopurine | - |
Severe acute respiratory syndrome-related coronavirus | |
6-thioguanine | - |
Severe acute respiratory syndrome-related coronavirus | |
Cu2+ | 30% inhibition at 0.01 mM | Severe acute respiratory syndrome-related coronavirus | |
hydroxypyridine-2-thione-Zn(II) | - |
Severe acute respiratory syndrome-related coronavirus | |
additional information | enzyme structure, function and inhibition by designed antiviral compounds, overview. No inhibition by NSC158362. Selectivity of naphthalene-based enzyme inhibitors, overview | Severe acute respiratory syndrome-related coronavirus | |
N-(1,3-benzodioxol-5-ylmethyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
N-(3-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
N-(4-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
N-(4-methoxybenzyl)-1-(naphthalen-1-ylmethyl)piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
N-ethyl-N-phenyldithiocarbamic acid-Zn(II) | - |
Severe acute respiratory syndrome-related coronavirus | |
N-[(2-methoxypyridin-4-yl)methyl]-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
N-[3-(acetylamino)benzyl]-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | - |
Severe acute respiratory syndrome-related coronavirus | |
NSC158011 | - |
Severe acute respiratory syndrome-related coronavirus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
additional information | no effect by Mg2+, Ca2+, Mn2+, Co2+, and Ni2+ | Severe acute respiratory syndrome-related coronavirus | |
Zn2+ | the fingers domain of the enzyme contains a zinc ion that is tetrahedrally coordinated by four cysteines | Severe acute respiratory syndrome-related coronavirus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Severe acute respiratory syndrome-related coronavirus | - |
from the Guangdong Province of China | - |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
responsible for the cleavages located at the N-terminus of the replicase polyprotein | catalytic cycle and proposed chemical mechanism of the SARS-coronavirus papain-like protease catalyzed reaction, of the catalytic triad residues Cys112 acts as nucleophile, His273 functions as a general acid-base, and Asp287 is paired with histidine helping to align it and promote deprotonation of Cys112, structure-function relationship, overview | Severe acute respiratory syndrome-related coronavirus |
Synonyms | Comment | Organism |
---|---|---|
PLpro | - |
Severe acute respiratory syndrome-related coronavirus |
SARS-coronavirus papain-like protease | - |
Severe acute respiratory syndrome-related coronavirus |
SARS-CoV papain-like protease | - |
Severe acute respiratory syndrome-related coronavirus |
SARS-CoV PLpro | - |
Severe acute respiratory syndrome-related coronavirus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00049 | - |
5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide | pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00015 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-(3-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | |
0.00032 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-(1,3-benzodioxol-5-ylmethyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | |
0.00035 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-[(2-methoxypyridin-4-yl)methyl]-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | |
0.00039 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-[3-(acetylamino)benzyl]-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | |
0.00049 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-(4-fluorobenzyl)-1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidine-4-carboxamide | |
0.0006 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide | |
0.0008 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 1,6,6-trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione | |
0.0033 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-ethyl-N-phenyldithiocarbamic acid-Zn(II) | |
0.0037 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | hydroxypyridine-2-thione-Zn(II) | |
0.0041 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | (4E)-1,7-bis(3,4-dihydroxyphenyl)hept-4-en-3-one | |
0.005 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 6-thioguanine | |
0.005 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | (7R)-5,7-dihydroxy-8-(4-hydroxy-3-methoxyphenyl)-2-(4-hydroxy-4-methylpentyl)-2-methyl-3,4,7,8-tetrahydro-2H,6H-pyrano[3,2-g]chromen-6-one | |
0.0087 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 2-methyl-N-[(1R)-1-(naphthalen-2-yl)ethyl]benzamide | |
0.0201 | - |
racemate, pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 2-methyl-N-[1-(naphthalen-2-yl)ethyl]benzamide | |
0.0216 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | 6-Mercaptopurine | |
0.059 | - |
pH and temperature not specified in the publication | Severe acute respiratory syndrome-related coronavirus | N-(4-methoxybenzyl)-1-(naphthalen-1-ylmethyl)piperidine-4-carboxamide |
General Information | Comment | Organism |
---|---|---|
additional information | enzyme structure and function, active site structure with catalytic triad residues, Cys112, His273 and Asp287 and the oxyanion hole-stabilizing residue Trp107, and catalytic mechanism, detailed overview. The fingers domain of PLpro, which contains a zinc ion that is tetrahedrally coordinated by four cysteines, is essential for catalysis because it maintains the structural integrity of the enzyme | Severe acute respiratory syndrome-related coronavirus |
physiological function | the primary function of the enzyme is to process the viral polyprotein in a coordinated manner. An additional function of the enzyme is stripping ubiquitin and ISG15 from host-cell proteins to aid the coronavirus in the evasion of the host innate immune responses, enzyme innate immune functions, overview | Severe acute respiratory syndrome-related coronavirus |